Robert J. Gould, Director at Fulcrum Therapeutics, Inc. (FULC), sold 15,000 shares at $11.03 ($165K) on 2025-11-19, disclosed to the SEC on 2025-11-21.
Open-market sale of $165k FULC by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| FULC | SELL | 2026-01-06 | $356K | — | Filing → |
| FULC | SELL | 2023-01-13 | $101K | — | Filing → |
| FULC | SELL | 2022-06-08 | $1.2M | — | Filing → |